@article{441815d31d78455dbab41112322e433a,
title = "Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?",
abstract = "N/A",
keywords = "Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease, Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease",
author = "Francesco Panza and Madia Lozupone and Vittorio Dibello and Antonio Greco and Antonio Daniele and Davide Seripa and Giancarlo Logroscino and Imbimbo, \{Bruno P\}",
year = "2019",
doi = "10.2217/imt-2018-0119",
language = "English",
volume = "11",
pages = "3--6",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Taylor and Francis Ltd.",
number = "1",
}